- Home
- OSUR vs AQST Comparison
OSUR vs AQST Comparison
Compare OSUR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- AQST
- Stock Information
- Founded
- OSUR 2000
- AQST 2004
- Country
- OSUR United States
- AQST United States
- Employees
- OSUR N/A
- AQST N/A
- Industry
- OSUR Medical/Dental Instruments
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- AQST Health Care
- Exchange
- OSUR Nasdaq
- AQST Nasdaq
- Market Cap
- OSUR 248.3M
- AQST 274.4M
- IPO Year
- OSUR 1986
- AQST 2018
- Fundamental
- Price
- OSUR $3.37
- AQST $3.04
- Analyst Decision
- OSUR Hold
- AQST Strong Buy
- Analyst Count
- OSUR 2
- AQST 6
- Target Price
- OSUR $5.50
- AQST $11.17
- AVG Volume (30 Days)
- OSUR 699.3K
- AQST 1.4M
- Earning Date
- OSUR 05-07-2025
- AQST 05-06-2025
- Dividend Yield
- OSUR N/A
- AQST N/A
- EPS Growth
- OSUR N/A
- AQST N/A
- EPS
- OSUR N/A
- AQST N/A
- Revenue
- OSUR $185,827,000.00
- AQST $57,561,000.00
- Revenue This Year
- OSUR N/A
- AQST N/A
- Revenue Next Year
- OSUR $7.46
- AQST $39.51
- P/E Ratio
- OSUR N/A
- AQST N/A
- Revenue Growth
- OSUR N/A
- AQST 13.79
- 52 Week Low
- OSUR $2.69
- AQST $2.24
- 52 Week High
- OSUR $6.35
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- OSUR 45.10
- AQST 51.97
- Support Level
- OSUR $3.34
- AQST $3.05
- Resistance Level
- OSUR $3.56
- AQST $3.24
- Average True Range (ATR)
- OSUR 0.15
- AQST 0.19
- MACD
- OSUR -0.00
- AQST 0.01
- Stochastic Oscillator
- OSUR 10.53
- AQST 48.53
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.